Surgery and stereotactic radiosurgery for spinal leiomyosarcoma: a single-institution retrospective series and systematic review

Author:

Zamarud Aroosa1,Marianayagam Neelan J.1,Sekar Vashisht1,Testa Stefano2,Park David J.1,Yener Ulas1,McCleary Tamra-Lee1,Yoo Kelly H.1,Emrich Sara1,Tayag Armine1,Ustrzynski Louisa1,Pollom Erqi3,Soltys Scott3,Wang Lei3,Charville Greg4,Ganjoo Kristen2,Chang Steven D.1,Meola Antonio1

Affiliation:

1. Departments of Neurosurgery,

2. Medicine, and

3. Radiation Oncology,

4. Pathology, Stanford University, Stanford, California

Abstract

OBJECTIVE Leiomyosarcoma (LMS) is a rare, aggressive soft-tissue sarcoma that seldom spreads to the bone. The spine can be either the site of LMS osseous metastases or the primary tumor site. The optimal treatment option for spinal LMS is still unclear. The authors present a cohort of patients with spinal LMS treated with either upfront surgery or upfront CyberKnife stereotactic radiosurgery (SRS). METHODS The authors retrospectively studied the clinical and radiological outcomes of 17 patients with spinal LMS treated at their institution between 2004 and 2020. Either surgery or SRS was used as the upfront treatment. The clinical and radiological outcomes were assessed. A systematic review of the literature was also conducted. RESULTS Of the 17 patients (20 spinal lesions), 12 (70.6%) were female. The median patient age was 61 years (range 41–80 years). Ten patients had upfront surgery for their spinal lesions, and 7 had upfront CyberKnife radiosurgery. The median follow-up was 11 months (range 0.3–130 months). The median overall survival (OS) for the entire cohort was 13 months (range 0.3–97 months). In subgroup analysis, the median OS was lower for the surgical group (13 months, range 0.3–50 months), while the median OS for the SRS group was 15 months (range 5–97 months) (p = 0.5). Forty percent (n = 4) of those treated with surgery presented with local recurrence at a median of 6.7 months (range 0.3–36 months), while only 14% (n = 1) of those treated with CyberKnife radiosurgery had local recurrence after 5 months. Local tumor control (LTC) rates at the 6-, 12-, and 18-month follow-ups were 72%, 58%, and 43%, respectively, for the SRS group and 40%, 30%, and 20%, respectively, for the surgery group (p < 0.05). The literature review included 35 papers with 70 patients harboring spinal LMS; only 2 patients were treated with SRS. The literature review confirms the clinical and radiological outcomes of the surgical group, while data on SRS are anecdotal. CONCLUSIONS The authors present the largest series in the literature of spinal LMS and the first on SRS for spinal LMS. This study shows that LTC is statistically significantly better in patients receiving upfront SRS instead of surgery. The OS does not appear different between the two groups.

Publisher

Journal of Neurosurgery Publishing Group (JNSPG)

Subject

General Medicine

Reference50 articles.

1. Prevalence of malignant soft tissue tumors in extremities: an epidemiological study in syria;Reshadi H,2014

2. StatPearls;Mangla A,2022

3. Bone metastases in patients with leiomyosarcoma: a retrospective analysis of survival and surgical management;LiBrizzi CL,2022

4. Metastatic pattern of uterine leiomyosarcoma: retrospective analysis of the predictors and outcome in 113 patients;Tirumani SH,2014

5. Leiomyosarcoma metastases to the spine. Case series and review of the literature;Elhammady MS,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3